212 related articles for article (PubMed ID: 20699706)
1. Functional sorbents for selective capture of plutonium, americium, uranium, and thorium in blood.
Yantasee W; Sangvanich T; Creim JA; Pattamakomsan K; Wiacek RJ; Fryxell GE; Addleman RS; Timchalk C
Health Phys; 2010 Sep; 99(3):413-9. PubMed ID: 20699706
[TBL] [Abstract][Full Text] [Related]
2. Selective capture of radionuclides (U, Pu, Th, Am and Co) using functional nanoporous sorbents.
Yantasee W; Fryxell GE; Pattamakomsan K; Sangvanich T; Wiacek RJ; Busche B; Addleman RS; Timchalk C; Ngamcherdtrakul W; Siriwon N
J Hazard Mater; 2019 Mar; 366():677-683. PubMed ID: 30580142
[TBL] [Abstract][Full Text] [Related]
3. Biomimetic actinide chelators: an update on the preclinical development of the orally active hydroxypyridonate decorporation agents 3,4,3-LI(1,2-HOPO) and 5-LIO(Me-3,2-HOPO).
Abergel RJ; Durbin PW; Kullgren B; Ebbe SN; Xu J; Chang PY; Bunin DI; Blakely EA; Bjornstad KA; Rosen CJ; Shuh DK; Raymond KN
Health Phys; 2010 Sep; 99(3):401-7. PubMed ID: 20699704
[TBL] [Abstract][Full Text] [Related]
4. From early prophylaxis to delayed treatment: Establishing the plutonium decorporation activity window of hydroxypyridinonate chelating agents.
An DD; Kullgren B; Jarvis EE; Abergel RJ
Chem Biol Interact; 2017 Apr; 267():80-88. PubMed ID: 27038878
[TBL] [Abstract][Full Text] [Related]
5. Actinide sequestration using self-assembled monolayers on mesoporous supports.
Fryxell GE; Lin Y; Fiskum S; Birnbaum JC; Wu H; Kemner K; Kelly S
Environ Sci Technol; 2005 Mar; 39(5):1324-31. PubMed ID: 15787373
[TBL] [Abstract][Full Text] [Related]
6. Lauriston S. Taylor Lecture: the quest for therapeutic actinide chelators.
Durbin PW
Health Phys; 2008 Nov; 95(5):465-92. PubMed ID: 18849679
[TBL] [Abstract][Full Text] [Related]
7. ENCAPSULATED 3,4,3-LI(1,2-HOPO) IN CHITOSAN NANOPARTICLES FOR DECORPORATION VIA INHALATION.
Chen S; Ko R; Lai EPC; Wyatt H; Abergel RJ; Li C
Radiat Prot Dosimetry; 2018 Dec; 182(1):107-111. PubMed ID: 30165556
[TBL] [Abstract][Full Text] [Related]
8. Decorporation of Pu/Am Actinides by Chelation Therapy: New Arguments in Favor of an Intracellular Component of DTPA Action.
Grémy O; Laurent D; Coudert S; Griffiths NM; Miccoli L
Radiat Res; 2016 Jun; 185(6):568-79. PubMed ID: 27195610
[TBL] [Abstract][Full Text] [Related]
9. Actinide-contaminated Skin: Comparing Decontamination Efficacy of Water, Cleansing Gels, and DTPA Gels.
Tazrart A; Bolzinger MA; Lamart S; Coudert S; Angulo JF; Jandard V; Briançon S; Griffiths NM
Health Phys; 2018 Jul; 115(1):12-20. PubMed ID: 29787426
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo evaluation of a novel ferrocyanide functionalized nanopourous silica decorporation agent for cesium in rats.
Timchalk C; Creim JA; Sukwarotwat V; Wiacek R; Addleman RS; Fryxell GE; Yantasee W
Health Phys; 2010 Sep; 99(3):420-9. PubMed ID: 20699707
[TBL] [Abstract][Full Text] [Related]
11. Actinide chelation: biodistribution and in vivo complex stability of the targeted metal ions.
Kullgren B; Jarvis EE; An DD; Abergel RJ
Toxicol Mech Methods; 2013 Jan; 23(1):18-26. PubMed ID: 22957518
[TBL] [Abstract][Full Text] [Related]
12. Structure of a single model to describe plutonium and americium decorporation by DTPA treatments.
Fritsch P; Sérandour AL; Grémy O; Phan G; Tsapis N; Fattal E; Benech H; Deverre JR; Poncy JL
Health Phys; 2010 Oct; 99(4):553-9. PubMed ID: 20838098
[TBL] [Abstract][Full Text] [Related]
13. Ustur Case 0846: Modeling Americium Biokinetics after Intensive Decorporation Therapy.
Breustedt B; Avtandilashvili M; McComish SL; Tolmachev SY
Health Phys; 2019 Aug; 117(2):168-178. PubMed ID: 30489383
[TBL] [Abstract][Full Text] [Related]
14. Incorporation of hydroxypyridinone ligands into self-assembled monolayers on mesoporous supports for selective actinide sequestration.
Lin Y; Fiskum SK; Yantasee W; Wu H; Mattigod SV; Vorpagel E; Fryxell GE; Raymond KN; Xu J
Environ Sci Technol; 2005 Mar; 39(5):1332-7. PubMed ID: 15787374
[TBL] [Abstract][Full Text] [Related]
15. Actinide Decorporation: A Review on Chelation Chemistry and Nanocarriers for Pulmonary Administration.
Lai EPC; Li C
Radiat Res; 2022 Oct; 198(4):430-443. PubMed ID: 35943882
[TBL] [Abstract][Full Text] [Related]
16. A 3,2-Hydroxypyridinone-based Decorporation Agent that Removes Uranium from Bones In Vivo.
Wang X; Dai X; Shi C; Wan J; Silver MA; Zhang L; Chen L; Yi X; Chen B; Zhang D; Yang K; Diwu J; Wang J; Xu Y; Zhou R; Chai Z; Wang S
Nat Commun; 2019 Jun; 10(1):2570. PubMed ID: 31239437
[TBL] [Abstract][Full Text] [Related]
17. Polyethyleneimine methylphosphonate: towards the design of a new class of macromolecular actinide chelating agents in the case of human exposition.
Lahrouch F; Sofronov O; Creff G; Rossberg A; Hennig C; Den Auwer C; Di Giorgio C
Dalton Trans; 2017 Oct; 46(40):13869-13877. PubMed ID: 28971198
[TBL] [Abstract][Full Text] [Related]
18. On the sequential separation and quantification of
Vasile M; Jacobs K; Bruggeman M; Van Hoecke K; Dobney A; Verrezen F
Appl Radiat Isot; 2018 Apr; 134():455-460. PubMed ID: 28735687
[TBL] [Abstract][Full Text] [Related]
19. Use of an Acellular Assay to Study Interactions between Actinides and Biological or Synthetic Ligands.
Van der Meeren A; Berthomieu C; Moureau A; Defrance M; Griffiths NM
Biomolecules; 2022 Oct; 12(11):. PubMed ID: 36358903
[TBL] [Abstract][Full Text] [Related]
20. On the structure of thorium and americium adenosine triphosphate complexes.
Mostapha S; Fontaine-Vive F; Berthon L; Boubals N; Zorz N; Solari PL; Charbonnel MC; Den Auwer C
Int J Radiat Biol; 2014 Nov; 90(11):966-74. PubMed ID: 24499480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
